(Stroke. 2000;31:1721.)
© 2000 American Heart Association, Inc.
Original Contributions |
From the Department of Pathology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.
Correspondence to Marc R. Del Bigio, MD, PhD, FRCPC, Department of Pathology, University of Manitoba, D212-770 Bannatyne Ave, Winnipeg, MB R3E 0W3 Canada. E-mail delbigi{at}cc.umanitoba.ca
| Abstract |
|---|
|
|
|---|
MethodsEighty-seven adult rats were subjected to intracortical injections of autologous whole blood or allogeneic plasma, erythrocytes, leukocytes, "activated" leukocytes, and serum. Injections of saline or mineral oil were controls. Blood injections were compared with cortical freeze injury and pial devascularization. Rats were perfusion-fixed 48 hours after injection or lesioning. Eosinophilic neurons, TUNEL-positive cells, brain damage area, infiltrating neutrophils, and CD8a-immunoreactive lymphocytes were quantified.
ResultsDamage area, dying cells, and inflammatory infiltrate were significantly greater after autologous whole blood, leukocyte, and "activated" leukocyte injections than injection of other fractions.
ConclusionsThese results suggest that extravasated whole blood causes a greater degree of cortical cell death and inflammation than ischemic lesions of similar size. Leukocytes "activated" by systemic illness might exacerbate the injury. Secondary hemorrhagic phenomena suggest that the harmful effect is directed toward both brain cells and the vasculature. Further studies are required to delineate the mechanism(s).
Key Words: hematoma inflammation in situ nick-end labeling lymphocytes neutrophils
| Introduction |
|---|
|
|
|---|
, interleukin-6,
and interferon-
(IFN-
), which might play an important role in
ischemic and traumatic brain damage.14 15 16 Work
from one group has suggested that thrombin and erythrocyte degradation
products are responsible for edema
production.8 11 17 18 An understanding of evolution of brain injury after intracortical hemorrhage is important to determine the strategy of treatment. Therefore, the purpose of this study was to investigate the early effects of autologous whole blood and compare its effect with that of separated blood components after intracortical injection. We hypothesized that cellular components of blood would cause greater cortical cell death and inflammation than soluble blood proteins. We have chosen a survival period of 48 hours because we have observed that inflammation and the frequency of dying cells both peak 48 to 72 hours after intracerebral injections of autologous blood19 and after pial devascularization (unpublished data). To test the secondary hypothesis that hemorrhagic brain injury causes more inflammation than nonhemorrhagic injury, we compared the damage caused by blood product injections with that caused by cortical freeze injury20 21 22 and pial devascularization.23 24 25
| Materials and Methods |
|---|
|
|
|---|
|
Intracortical Hemorrhage Model
For cortical injection, each rat was anesthetized with
pentobarbital (50 mg/kg IP) and placed in a stereotactic
frame. Under aseptic conditions, a midline scalp incision was made, a
hole was drilled in the skull (3 mm lateral to midline and
0.02 mm anterior to coronal suture), a 100-µL syringe was
secured to the frame, and a 25-gauge needle was introduced into the
deep cerebral cortex 2.5 mm below the surface of the skull. Pilot
experiments wherein blood was injected to these coordinates showed that
there was minimal extension into white matter or the
subarachnoid compartment after short survival. Each rat
received a 50-µL injection of either normal saline, plasma, serum,
erythrocytes, leukocytes, "activated" leukocytes,
autologous whole blood, or mineral oil over a period of 5 minutes.
Mineral oil was chosen as additional inert control because it has
greater viscosity than saline and was expected to better mimic the
minimal space-occupying effect of the infused blood. After infusion,
the needle was left in place for 3 minutes and then removed slowly. The
bone hole was sealed with bone wax, the scalp wound was sutured, and
the animal was placed in a clean cage with free access to food and
water. Invasive physiological monitoring was not
used because it significantly increased the anesthesia
time.
Whole Blood and Blood Component Separation
Autologous whole blood was obtained from anesthetized
rats by placing the tail end in 40°C water for 30 seconds followed by
cleansing with 70% alcohol and cutting the tail
10 mm from
tail tip. Freely dripping whole blood (50 µL) was collected in a
sterile syringe, which was then affixed to the stereotactic
frame and immediately injected into the cerebral cortex. To obtain
allogeneic blood components, 2 donor rats were anesthetized
with pentobarbital and 5 mL blood was removed from the heart. Fresh
blood was put in CPD anticoagulation preservative,26
gently mixed in a sterile plastic tube, and centrifuged at
2200g for 20 minutes. Plasma appeared in the upper layer,
leukocytes and platelets formed a thin intermediate layer, and
concentrated erythrocytes were in the lower layer.26
To further concentrate the leukocytes, plasma was removed and the
leukocytes were put in a 2-mm-diameter sterile glass tube and
centrifuged at 2200g for 20 minutes. These were
stored in a sterile vial for up to 2 hours before injection. To obtain
autologous serum, rats were anesthetized and 0.5 mL whole blood
was collected from the tail in a sterile vial as described above. After
1 hour at room temperature, the blood coagulated. Serum was separated
after clot retraction and stored up to 3 hours before injection.
To obtain allogeneic "activated" leukocytes, cardiac blood was obtained from 2 rats 24 hours after intracortical injection of autologous blood, which had been performed as described above. The rationale for this approach is that acute subarachnoid and intracerebral hemorrhages cause acute elevations in circulating leukocytes, especially neutrophils.27 28 29
Freeze and Pial Devascularization Lesions
We observed that injections of autologous whole blood were
frequently associated with lesions much larger than the area directly
infused with blood. To test the secondary hypothesis that hemorrhagic
brain injury causes more inflammation than nonhemorrhagic injury, we
attempted to create relatively nonhemorrhagic lesions of similar size
in a similar dorsal cortical location. For induction of cortical freeze
lesion, rats were anesthetized with pentobarbital and placed in
a stereotactic frame. The scalp was incised along the
midline. A copper rod (end diameter 2 mm) cooled to -170°C in
liquid nitrogen was applied to the skull surface for 4 minutes (3
mm lateral to midline, 0.02 mm anterior to coronal suture). The
scalp wound was sutured, and the animal was placed in a clean cage with
free access to food and water. To study the early
histological changes, rats were killed 4, 8, and 24
hours (n=2 each) after freezing in addition to the 48-hour survival
period used for comparison with blood injections.
For pial devascularization, rats were anesthetized and placed in a stereotactic frame. The scalp was incised along the midline. A rectangle 3 mm wide and 5 mm long was delineated in the right hemiskull, the rostral margin 1 mm anterior to the bregma, and the medial margin 1 mm lateral to the midline. The bone was removed carefully by enlarging a drill hole with rongeurs. Cortical blood vessels were interrupted by gently pulling the pia/arachnoid away with a needle (23 gauge) bent at the tip.30 Hemostasis was achieved by gentle tamponade with cotton-tipped applicators. The bone hole was covered with surrounding soft tissue, the scalp wound was sutured, and the animal was placed in a clean cage with free access to food and water. Rats were killed 4, 8, 24 (n=2 each), and 48 hours (n=4) after pial devascularization.
Histological Examination
Forty-eight hours after intracortical injection or lesioning,
rats were anesthetized and perfused through the heart with 300
mL of ice-cold 4% paraformaldehyde in 0.1 mol/L PBS.
The brain was removed and stored in the same fixative for up to 10
days. Fixed brains were cut coronally
2 mm on either side of
the needle entry site, which was identifiable on the brain surface.
Brain slices were dehydrated and embedded in paraffin. Sections (6
µm) were cut, and each 30th section from the rostral to the caudal
portion of the residual hematoma cavity was stained with hematoxylin
and eosin stain. At the level of the needle site with maximal brain
damage area, a variety of histological and
immunohistochemical stains were performed. Chloracetate esterase
staining was used to assess neutrophils. Sections were dewaxed and
hydrated, washed with distilled water, and incubated for 60 minutes in
4% sodium nitrite, 4% new fuchsin, and 1% esterase substrate
solution (naphthol AS-D chloroacetate dissolved in N-N
dimethyl formamide) in phosphate buffer at pH 7.4. Slides were washed
with distilled water, counterstained with Mayers hematoxylin for 3
minutes, dehydrated, cleared, and mounted. Neutrophilic granulocyte
cytoplasm was stained bright red. Immunohistochemical localization of
CD8a was performed.31 Sections were dewaxed and
hydrated, washed with distilled water, quenched with 0.3%
H2O2, blocked with 10%
normal serum, and incubated with anti-rat CD8a monoclonal antibody
(clone G28 diluted 1:400; PharMingen International) at 4°C
overnight. Slides were then washed with Triton PBS, incubated in
biotinylated goat anti-mouse IgG (1:300) 1 hour at room temperature,
washed, incubated with peroxidase-HRP (1:400) for 30 minutes at room
temperature, colored with
diaminobenzidine-H2O2
solution, washed, and coverslipped. Control sections were processed
with omission of the primary antibody. TUNEL (terminal
deoxynucleotidyl transferase [TdT]-mediated
deoxyuridine triphosphate [dUTP]-biotin nick end labeling) was used
to identify dying cells. Paraffin-embedded sections were dewaxed and
hydrated, then incubated in 20 µL/ml proteinase K for 15 minutes.
TUNEL was accomplished with the use of an Apoptag in situ kit
(Intergen). After immersion in equilibration buffer for 10 minutes,
sections were incubated with TdT and dUTP-digoxigenin in a humidified
chamber at 37°C for 1 hour and then incubated in the stop/wash buffer
at 37°C for 30 minutes. Sections were washed with PBS before
incubation in antidigoxigenin-peroxidase solution (1:500 in PBS) for
30 minutes at room temperature and colored with
diaminobenzidine-H2O2
solution. Sections were counterstained with methyl green. Negative
control sections were treated similarly but incubated in the absence of
TdT enzyme, dUTP-digoxigenin, or anti-digoxigenin antibody.
TUNEL-positive nuclei with chromatin condensation and fragmented nuclei
were considered as probable apoptotic cells. TUNEL-positive
cells with diffuse light-brown labeling of nucleus and cytoplasm were
considered as probable necrotic cells.32
Determination of Damaged Brain Area
The area of brain damage on the hematoxylin and eosinstained
coronal slice at the level of the needle injection site was defined by
the presence of blood collections, tissue rarefaction caused by edema,
and dying cells around the injection sites. Computerized planimetry was
used to measure the damage area on "camera lucida" drawings of the
brain section.
Cell Counts
Although the observer was technically blinded to the nature of
the injection, because of some obvious differences (for example,
between whole-blood and saline injections), blinding in an absolute
sense was not possible. With the use of an ocular graticule and x250
ocular magnification (objective magnification x20), eosinophilic
neurons, neutrophils, CD8a immunoreactive cells, and TUNEL-positive
dying cells were counted in 4 randomly selected fields (each area
250x250 µm) adjacent to but not including the needle
insertion/injection site, which was defined by the presence of
erythrocytes in all cases (see Figure 1
).
Areas with large blood vessels were avoided. In brains with large areas
of damage after autologous blood injection, similar counts were made at
the edge of the lesion, distant from the injection site. Cortical
freeze and pial devascularization lesions were assessed in 4 randomly
selected areas at the periphery of the lesions.
|
Data Analysis
All data are expressed as mean±SD. Data were analyzed
with StatView 5 software (SAS Institute Inc). ANOVA with the
Bonferroni-Dunn test was used for intergroup comparisons. Fishers
r to z test was used for correlations.
| Results |
|---|
|
|
|---|
Microscopically, whole-blood injections appeared as single or multiple contiguous collections of blood cells in a column surrounding the needle tract. Leukocyte injections appeared as smaller collections of intact neutrophils and fragmented leukocytes with nuclear debris. Small collections of blood cells around the needle insertion site were seen all in other groups. In the vicinity of all lesions, neutrophils were seen adherent to blood vessel walls or passing out of capillaries and venules into the neuropil. Eosinophilic neurons, TUNEL-positive cells with nuclear labeling presumed to indicate apoptosis, and TUNEL-positive cells with cytoplasmic labeling presumed to indicate necrosis32 were detected in cortical damage areas. Cells that exhibited membrane immunoreactivity for CD8a were small, with minimal cytoplasm and round nuclei. On the basis of the morphology of the cells and the known specificity of the antibody,31 we believe these to be natural killer (NK) cells and/or activated cytotoxic T-lymphocytes. Neutrophils were also noted in the subarachnoid compartment adjacent to the needle entry sites and at sites of subarachnoid hemorrhage.
Quantitative analysis showed that the total area of cortical
damage was significantly larger after injection of 50 µL of whole
blood or "activated" leukocytes than other blood fractions
(Table 1
), particularly when there was associated
subarachnoid hemorrhage. At the microscopic level,
eosinophilic neurons, TUNEL-positive dying cells, neutrophils, and
CD8a-immunoreactive lymphocytes adjacent to the injection site were
significantly more abundant after whole-blood, leukocyte, and
"activated" leukocyte injections than the other groups
(Table 1
). For the population as a whole, the quantities of
dying cells and inflammatory cells were all intercorrelated
(r=0.556 to 0.795, P<0.0001). The total damage
area correlated poorly with TUNEL-positive cells and eosinophilic
neurons per unit area in microscopic fields (r=0.412 and
0.544 respectively, P<0.001) and not with the inflammation.
Comparison of microscopic changes between the core and edge of
hemorrhagic lesions that had enlarged beyond the site of whole-blood
injection showed that the quantity of dying cells and inflammatory
cells was approximately half at the periphery.
To test the secondary hypothesis that hemorrhagic brain lesions are
associated with more inflammation than nonhemorrhagic lesions, we
compared the lesions that had enlarged after whole-blood injections
with freeze lesions and pial devascularizing lesions in the dorsal
cortex (Figure 2
and Table 2
). Our goal was to create lesions of
similar size in the same location, but we did not entirely succeed in
this respect. Pial devascularization lesions exhibited a mixture of
edematous and hemorrhagic brain at 8 hours, as previously
documented.25 By 48 hours, the core was necrotic, and
damage extended laterally to the margins of the craniectomy and deep to
the white matter. Freeze lesions were pale on gross inspection, and
only microscopic petechiae were noted 8 hours after freezing. By 48
hours, the majority of cells in the central region were necrotic, with
no basophilic staining of the nuclei. The surrounding viable brain was
rarefied as the result of edema. The core of all large lesions
exhibited advanced necrosis with only vague cell outlines apparent,
absence of chromatin staining, minimal inflammation, and only very rare
TUNEL-positive cells. The margins of these lesions were edematous and
exhibited both dying cells and inflammation. At the microscopic level,
lesions associated with blood injections exhibited more inflammation
and cell death than the partially hemorrhagic devascularizing lesion
and the relatively nonhemorrhagic freeze lesions (Table 2
).
|
|
| Discussion |
|---|
|
|
|---|
20 µL erythrocytes,
25 µL
plasma, and
2 µL leukocytes to account for the true relative
volumes of these blood fractions. We were, however, concerned that this
would be confounded by different volumes of dispersion. Had this been
done, the effect of erythrocytes and plasma, which were not
significantly different than saline control, would have been even less.
The effect of the leukocytes might be exaggerated in the experimental
protocol that was used. After injection of the blood, we observed cell death, inflammatory cell infiltration, and in some cases distant hemorrhagic/ischemic damage. In the immediate vicinity of the injection site, neuronal death was characterized by DNA damage and cytoplasmic hypereosinophilia. Although it is likely that the 2 features represent cells at different stages of death or those dying by different mechanisms (ie, apoptosis or necrosis), our data do not add anything to explain the mechanism of delayed neuronal cell death, a subject of heated debate.35 36 37 Reactive neuronal expression of heat shock protein (HSP72) and/or loss of MAP2 immunoreactivity indicative of proteolysis and impending death has been documented within 5 hours after intracerebral hemorrhage in humans. Increased astroglial expression of glial fibrillary acidic protein and metallothionein occurs within 18 to 48 hours.38
Inflammation is an obvious response to the injections. Although one
might argue that the neutrophils had been injected and had not entered
by diapedesis, we attempted to count cells only beyond the margin of
the primary injection site. Substantial margination of leukocytes along
the blood vessel lumen supports the idea that they subsequently enter
the brain tissue. Chemotaxis of these neutrophils and lymphocytes, and
later of monocytes, is mediated by
- and ß-chemokines and
complement.39 40 In rat brain injury experiments,
intense neutrophilic infiltrate has been previously documented around
collagenase-induced hematomas,5 13
contusions,41 42 and ischemic sites43
beginning at 6 to 12 hours and peaking at 48 to 72 hours. In human
brains, neutrophil infiltration is apparent 5 to 72 hours after
hemorrhage or contusion.1 38 44 45 46 The
present experimental comparison of hemorrhagic and nonhemorrhagic
lesions suggests that something in, or a process initiated by,
extravasated blood promotes chemotaxis. Neutrophils can release
potentially harmful factors such as oxygen radicals47 or
cytokines including tumor necrosis factor-
, interleukin-6,
and IFN-
, which seem to play a role in brain
damage.15 16 Neutrophils can also exacerbate brain injury
by obstructing microvessels, which then causes local
ischemia.48 Many experimental studies have
documented infiltration of NK cells into injured
brain.39 49 50 One study of brain contusions in rats
showed that NK and T-cell infiltration was more prevalent than
neutrophilic infiltrate.51 We also observed a significant
number of CD8a-immunoreactive cells, which could be either NK cells
and/or activated cytotoxic T-lymphocytes31 that
could be directly injurious or indirectly so through release of
IFN-
.
We observed that the injection of whole blood or the leukocyte fraction caused injury, whereas injection of erythrocytes, plasma, and serum had minimal effects. However, it is conceivable that specific blood/plasma fractions exert damage at different times. Other investigators showed that cerebral edema develops only 3 days after erythrocyte injection, and they suggested that hemoglobin released from lysed erythrocytes is toxic to brain.11 The toxic effect of hemoglobin on neurons has been demonstrated in vitro.52 In this study, neither plasma nor serum caused more damage than saline injection. Thrombin, which is a component of plasma, has been shown to cause brain edema and seizures after intracerebral injection.8 33 53 There are several possible explanations for the discrepancy. The thrombin effect might be mediated only by very large doses and is therefore relatively less important in vivo. Thrombin might for some reason be inactivated during processing of the plasma. Finally, the "pharmacodynamics" might be altered because a blood clot allows slow focal release whereas plasma injection would diffuse rapidly leading to lower regional concentrations.
The leukocyte fraction, and in particular "activated" leukocytes, caused greater injury than other blood fractions. When one interprets the intensity of the leukocyte-mediated response, one must keep in mind that leukocytes occupy <1% of the volume of whole blood. Therefore, the leukocyte injection groups received a dose equivalent to 5 mL of whole blood.54 Regardless, "activated" cells appear to be more harmful, perhaps through production of more of the deleterious mediators mentioned above. This might help to explain the observation that fever during the first 3 days after intracerebral hemorrhage is an independent predictor of poor prognosis in patients.55 To further study the role of leukocytes in this model, one could inject microwave-killed cells whose proteins are inactivated, lysed cells, and supernatant from cultured cells in resting or active states. This would help to determine whether the noxious agents are actively or passively released. It is also important to recognize that activated platelets, which we did not study directly, are included in the leukocyte fraction. Platelets can release serotonin and platelet-derived growth factor, which are capable of increasing vascular permeability and causing vasoconstriction.56
Finally, we must try to explain why injection of some blood fractions was associated with enlargement of the lesions well beyond the limits of the injected substance. Several results suggest that mechanism other than mass effect are involved in the contribution of blood to perihematoma edema formation, because blood produces larger lesions than would be expected from its space occupying effects alone.57 This might be explained by a secondary effect of the injected substances on the vasculature through agents that promote vasospasm and/or increased vascular permeability.58 Whole blood has greater adverse effects on cerebral blood flow than hemoglobin or albumin when injected into the subarachnoid compartment, presumably because of vasoconstrictive agents.59 It is because of these larger lesions that we also used control injuries of freeze lesion, which creates ischemia and coagulative necrosis,20 and pial devascularization, which has been promoted as a model of ischemia.23 Our goal was to create large nonhemorrhagic lesions that could be compared with the lesions caused by blood injections. The freeze lesion was reasonably successful in this regard, having caused only minimal hemorrhage but considerable release of plasma.60 At the margin it was associated with considerably fewer dying cells and neutrophils than the whole blood injection. The devascularization injury was associated with deep hemorrhage that probably was a consequence of deep vein avulsion. This mixed hemorrhagic/ischemic lesion was associated with more dying and inflammatory cells than the freeze lesion but fewer than the whole-blood injection.
In conclusion, extravascular whole blood, and perhaps the leukocyte fraction in particular, appears to play an important role in cortical damage. The magnitude of delayed cell death and inflammation is greater than that after nonhemorrhagic injury. Although coexistent, we cannot state that inflammation is necessarily a cause of neural cell injury. The precise molecular and chemical mechanisms remain to be determined but probably are multiple and include secondary ischemia, inflammatory cell products, and iron-mediated effects.
| Acknowledgments |
|---|
Received December 13, 1999; revision received March 8, 2000; accepted April 10, 2000.
| References |
|---|
|
|
|---|
2. Taylor CL, Selman WR, Ratcheson RA. Brain attack: the emergent management of hypertensive hemorrhage. Neurosurg Clin North Am. 1997;8:237244.[Medline] [Order article via Infotrieve]
3. Bullock R, Mendelow AD, Teasdale GM, Graham DI. Intracranial hemorrhage induced at arterial pressure in the rat, I: description of technique, ICP changes and neuropathologic findings. Neurol Res. 1984;6:184188.[Medline] [Order article via Infotrieve]
4. Koeppen AH, Dickson AC, McEvoy JA. The cellular reactions to experimental intracerebral hemorrhage. J Neurol Sci. 1995;134:102112.
5.
Rosenberg GA, Mun-Bryce S, Wesley M, Kornfeld M.
Collagenase-induced intracerebral
hemorrhage in rats. Stroke. 1990;21:801807.
6.
Wagner KR, Xi GH, Hua Y, Kleinholz M, de Courten-Myers
GM, Myers RE, Broderick JP, Brott TG. Lobar
intracerebral hemorrhage model in pigs: rapid
edema development in perihematomal white matter. Stroke. 1996;27:490497.
7. Jenkins A, Maxwell WL, Graham DI. Experimental intracerebral hematoma in the rat: sequential light microscopical changes. Neuropathol Appl Neurobiol. 1989;15:477486.[Medline] [Order article via Infotrieve]
8. Lee KR, Colon GP, Betz AL, Keep RF, Kim S, Hoff JT. Edema from intracerebral hemorrhage: the role of thrombin. J Neurosurg. 1996;84:9196.[Medline] [Order article via Infotrieve]
9. Matz PG, Weinstein PR, Sharp FR. Heme oxygenase-1 and heat shock protein 70 induction in glia and neurons throughout rat brain after experimental intracerebral hemorrhage. Neurosurgery. 1997;40:152162.[Medline] [Order article via Infotrieve]
10. Peng Z-C, Li XQ, Li QH, Zhu CX, Luo TL, Yan XX, Hu SY. Induction of NADPH-diaphorase activity in the forebrain in a model of intracerebral hemorrhage and its inhibition by the traditional Chinese medicine complex Nao Yi An. Brain Res Bull. 1997;42:119128.[Medline] [Order article via Infotrieve]
11. Xi GH, Keep RF, Hoff JT. Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J Neurosurg. 1998;89:991996.[Medline] [Order article via Infotrieve]
12. Nath FP, Jenkins A, Mendelow AD, Graham DI, Teasdale GM. Early hemodynamic changes in experimental intracerebral hemorrhage. J Neurosurg. 1986;65:697703.[Medline] [Order article via Infotrieve]
13.
Del Bigio MR, Yan HJ, Buist R, Peeling J. Experimental
intracerebral hemorrhage in rats: magnetic
resonance imaging and histopathological correlates. Stroke. 1996;27:23122320.
14. Arvin B, Neville LF, Barone FC, Feuerstein GZ. The role of inflammation and cytokines in brain injury. Neurosci Biobehav Rev. 1996;20:445452.[Medline] [Order article via Infotrieve]
15. Ghirnikar RS, Lee YL, Eng LF. Inflammation in traumatic brain injury: role of cytokines and chemokines. Neurochem Res. 1998;23:329340.[Medline] [Order article via Infotrieve]
16. Munoz-Fernandez MA, Fresno M. The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol. 1998;56:307340.[Medline] [Order article via Infotrieve]
17. Lee KR, Betz AL, Kim S, Keep RF, Hoff JT. The role of the coagulation cascade in brain edema formation after intracerebral hemorrhage. Acta Neurochir. 1996;138:396401.[Medline] [Order article via Infotrieve]
18.
Xi GH, Wagner KR, Keep RF, Hua Y, de Courten-Myers GM,
Broderick JP, Brott TG, Hoff JT. Role of blood clot formation on early
edema development after experimental intracerebral
hemorrhage. Stroke. 1998;29:25802585.
19. Xue M, Del Bigio MR. Intracerebral injection of autologous whole blood in rats: time course of inflammation and cell death. Neurosci Lett.. 2000;283:230232.[Medline] [Order article via Infotrieve]
20. Clasen RA, Brown DVL, Leavitt S, Hass GM. The production by liquid nitrogen of acute closed cerebral lesions. Surg Gynecol Obstet. 1953;96:605616.[Medline] [Order article via Infotrieve]
21. Hass GM, Taylor CB. A quantitative hypothermal method for the production of local injury of tissue. Arch Pathol. 1948;45:563580.
22. Klatzo I, Piraux A, Laskowski EJ. The relationship between edema, blood-brain-barrier and tissue elements in a local brain injury. J Neuropathol Exp Neurol. 1958;17:548564.[Medline] [Order article via Infotrieve]
23. Elliott PJ, Garofalo L, Cuello AC. Limited neocortical devascularizing lesions causing deficits in memory retention and choline acetyltransferase activity: effects of the monosialoganglioside GM1. Neuroscience. 1989;31:6376.[Medline] [Order article via Infotrieve]
24. Russell IS, Hobbelen JF, Van Hof MW, Pereira SC. The effect of devascularization of the visual cortex on visual function in the rabbit. Behav Brain Res. 1984;14:6980.[Medline] [Order article via Infotrieve]
25. Sensharma GC, Singh S, Deb S. Changes in the brain following experimental extirpation of pia. Indian J Med Res. 1979;69:338343.[Medline] [Order article via Infotrieve]
26. Vengelen-Tyler V, ed. Technical Manual. 12th ed. Bethesda, Md: American Association of Blood Banks; 1996.
27. Parkinson D, Stephensen S. Leukocytosis and subarachnoid hemorrhage. Surg Neurol. 1984;21:132134.[Medline] [Order article via Infotrieve]
28. Spallone A, Acqui M, Pastore FS, Guidetti B. Relationship between leukocytosis and ischemic complications following aneurysmal subarachnoid hemorrhage. Surg Neurol. 1987;27:253258.[Medline] [Order article via Infotrieve]
29.
Suzuki S, Kelley RE, Dandapani BK, Reyes-Iglesias Y,
Dietrich WD, Duncan RC. Acute leukocyte and temperature response in
hypertensive intracerebral hemorrhage.
Stroke. 1995;26:10201023.
30. Herrera DG, Robertson HA. Unilateral induction of c-fos protein in cortex following cortical devascularization. Brain Res. 1989;503:205213.[Medline] [Order article via Infotrieve]
31. Torres-Nagel N, Kraus E, Brown MH, Tiefenthaler G, Mitnacht R, Williams AF, Hunig T. Differential thymus dependence of rat CD8 isoform expression. Eur J Immunol. 1992;22:28412848.[Medline] [Order article via Infotrieve]
32. Charriaut-Marlangue C, Ben-Ari Y. A cautionary note on the use of the TUNEL stain to determine apoptosis. Neuroreport. 1995;7:6164.[Medline] [Order article via Infotrieve]
33. Lee KR, Kawai N, Kim S, Sagher O, Hoff JT. Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. J Neurosurg. 1997;86:272278.[Medline] [Order article via Infotrieve]
34. Mendelow AD. Mechanisms of ischemic brain damage with intracerebral hemorrhage. Stroke. 1993;24(suppl I):I-115-I-117.
35.
Colbourne F, Sutherland GR, Auer RN. Electron
microscopic evidence against apoptosis as the mechanism of
neuronal death in global ischemia. J Neurosci. 1999;19:42004210.
36. Majno G, Joris I. Apoptosis, oncosis, and necrosis: an overview of cell death. Am J Pathol. 1995;146:315.[Abstract]
37. Roy M, Sapolsky R. Neuronal apoptosis in acute necrotic insults: why is the subject such a mess? Trends Neurosci. 1999;22:419422.[Medline] [Order article via Infotrieve]
38. Mackenzie JM, Clayton JA. Early cellular events in the penumbra of human spontaneous intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 1999;8:18.
39. Bona E, Andersson AL, Blomgren K, Gilland E, Puka-Sundvall M, Gustafson K, Hagberg H. Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats. Pediatr Res. 1999;45:500509.[Medline] [Order article via Infotrieve]
40. Lindsberg PJ, Ohman J, Lehto T, Karjalainen-Lindsberg ML, Paetau A, Wuorimaa T, Carpen O, Kaste M, Meri S. Complement activation in the central nervous system following blood-brain barrier damage in man. Ann Neurol. 1996;40:587596.[Medline] [Order article via Infotrieve]
41. Mathew P, Graham DI, Bullock R, Maxwell W, McCulloch J, Teasdale G. Focal brain injury: histological evidence of delayed inflammatory response in a new rodent model of focal cortical injury. Acta Neurochir Suppl. 1994;60:428430.[Medline] [Order article via Infotrieve]
42. Soares HD, Hicks RR, Smith D, McIntosh TK. Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J Neurosci. 1995;15:82238233.[Abstract]
43. Jean WC, Spellman SR, Nussbaum ES, Low WC. Reperfusion injury after focal cerebral ischemia: the role of inflammation and the therapeutic horizon. Neurosurgery. 1998;43:13821396.[Medline] [Order article via Infotrieve]
44. Holmin S, Biberfeld P, Mathiesen T. Intracerebral inflammation after human brain contusion. Neurosurgery. 1998;42:291299.[Medline] [Order article via Infotrieve]
45. Loberg EM, Torvik A. Brain contusions: the time sequence of the histological changes. Med Sci Law. 1989;29:109115.[Medline] [Order article via Infotrieve]
46. Anderson RM, Opeskin K. Timing of early changes in brain trauma. Am J Forensic Med Pathol. 1998;19:19.[Medline] [Order article via Infotrieve]
47. Ikeda Y, Long DM. The molecular basis of brain injury and brain edema: the role of oxygen free radicals. Neurosurgery. 1990;27:111.[Medline] [Order article via Infotrieve]
48.
del Zoppo GJ, Von Kummer R, Hamann GF. Ischaemic damage
of brain microvessels: inherent risks for thrombolytic
treatment in stroke. J Neurol Neurosurg Psychiatry. 1998;65:19.
49. Montero-Menei CN, Sindji L, Pouplard-Barthelaix A, Jehan F, Denechaud L, Darcy F. Lipopolysaccharide intracerebral administration induces minimal inflammatory reaction in rat brain. Brain Res. 1994;653:101111.[Medline] [Order article via Infotrieve]
50. Schroeter M, Jander S, Witte OW, Stoll G. Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion. J Neuroimmunol. 1994;55:195203.[Medline] [Order article via Infotrieve]
51. Holmin S, Mathiesen T, Shetye J, Biberfeld P. Intracerebral inflammatory response to experimental brain contusion. Acta Neurochir. 1995;132:110119.[Medline] [Order article via Infotrieve]
52. Regan RF, Guo Y. Toxic effect of hemoglobin on spinal cord neurons in culture. J Neurotrauma. 1998;15:645653.[Medline] [Order article via Infotrieve]
53. Lee KR, Drury I, Vitarbo E, Hoff JT. Seizures induced by intracerebral injection of thrombin: a model of intracerebral hemorrhage. J Neurosurg. 1997;87:7378.[Medline] [Order article via Infotrieve]
54. Weiss L. The blood. In: Weiss L, ed. Cell and Tissue Biology. 6th ed. Baltimore, Md: Urban and Schwarzenberg; 1988:425443.
55.
Schwarz S, Hafner K, Aschoff A, Schwab S. Incidence and
prognostic significance of fever following
intracerebral hemorrhage. Neurology.. 2000;54:354361.
56. Lee JY, Lee MY, Chung SM, Chung JH. Chemically induced platelet lysis causes vasoconstriction by release of serotonin. Toxicol Appl Pharmacol. 1998;149:235242.[Medline] [Order article via Infotrieve]
57. Jenkins A, Mendelow AD, Graham DI, Nath FP, Teasdale GM. Experimental intracerebral haematoma: the role of blood constituents in early ischaemia. Br J Neurosurg. 1990;4:4551.[Medline] [Order article via Infotrieve]
58. Akopov S, Sercombe R, Seylaz J. Cerebrovascular reactivity: role of endothelium/platelet/leukocyte interactions. Cerebrovasc Brain Metab Rev. 1996;8:1194.[Medline] [Order article via Infotrieve]
59. Cole DJ, McKay LD, Drummond JC, Patel PM, Cross LM. Subarachnoid molecular hemoglobin after subarachnoid hemorrhage in rats: effect on the area of hypoperfusion. J Neurosurg Anesthesiol. 1998;10:153159.[Medline] [Order article via Infotrieve]
60. Clasen RA, Cooke PM, Pandolfi S, Boyd D, Raimondi AJ. Experimental cerebral edema produced by focal freezing, I: an anatomic study utilizing vital dye techniques. J Neuropathol Exp Neurol. 1962;21:579596.[Medline] [Order article via Infotrieve]
Department of Neurosurgery, University of California, Davis, Sacramento, California
| Introduction |
|---|
|
|
|---|
Received December 13, 1999; revision received March 8, 2000; accepted April 10, 2000.
This article has been cited by other articles:
![]() |
L. Belayev, I. Saul, R. Busto, K. Danielyan, A. Vigdorchik, L. Khoutorova, and M. D. Ginsberg Albumin Treatment Reduces Neurological Deficit and Protects Blood-Brain Barrier Integrity After Acute Intracortical Hematoma in the Rat Stroke, February 1, 2005; 36(2): 326 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Xue and M. R. Del Bigio Acute Tissue Damage After Injections of Thrombin and Plasmin into Rat Striatum Stroke, September 1, 2001; 32(9): 2164 - 2169. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Meguro, B. Chen, A. D. Parent, and J. H. Zhang Caspase Inhibitors Attenuate Oxyhemoglobin-Induced Apoptosis in Endothelial Cells Stroke, February 1, 2001; 32(2): 561 - 566. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |